Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the bioinformatics in in-vitro diagnostics (ivd) testing market size evolved in recent years?
The bioinformatics in in-vitro diagnostics (IVD) testing market has grown strongly in recent years. It is projected to increase from $93.02 billion in 2024 to $99.69 billion in 2025, at a CAGR of 7.2%. The growth is driven by improved healthcare infrastructure, expansion of biobanks, a rising geriatric population, government initiatives, and the growth of personalized medicine.
What are the predictions for the bioinformatics in in-vitro diagnostics (ivd) testing market size in the coming years?
The bioinformatics in in-vitro diagnostics (IVD) testing market is expected to reach $129.89 billion by 2029, growing at a CAGR of 6.8%. Growth drivers include the rising prevalence of diseases, IT integration in healthcare, government initiatives, the shift toward personalized medicine, increased awareness about bioinformatics in diagnostics, and reduced genomic sequencing costs. Key trends include AI and machine learning, next-generation sequencing, point-of-care testing, cloud computing, and innovations in immunochemical techniques.
Get your bioinformatics in in-vitro diagnostics (ivd) testing market report here!
What key factors are fueling the growth of the bioinformatics in in-vitro diagnostics (ivd) testing market?
The increasing prevalence of cancer is projected to drive the growth of the bioinformatics in IVD testing market. Cancer, a leading cause of death worldwide, is on the rise due to lifestyle and environmental factors. Bioinformatics plays a critical role in improving cancer diagnosis by providing genetic insights that support early detection and treatment decisions. For instance, nearly 40% of US adults live with multiple chronic conditions, which increase the risk of cancer, driving the demand for bioinformatics in IVD testing.
How is the global bioinformatics in in-vitro diagnostics (ivd) testing market divided into key segments?
The bioinformatics in in-vitro diagnostics (IVD) testing market covered in this report is segmented –
1) By Type: Hardware, Software
2) By Type Of Test: Blood Based Tests, Tissue Based Tests
3) By Application: Cardiovascular Diseases, Chronic Diseases, Diabetes, Cancer, Other Applications
Subsegments:
1) By Hardware: Analyzers, Laboratory Equipment, Data Storage Devices, Sensors And Detectors, Workstations And Data Processing Hardware
2) By Software: Bioinformatics Platforms, Data Management and Integration Software, Analytics And Interpretation Software, Cloud-Based Software Solutions, AI-Based Software For Diagnostics
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16629&type=smp
Who are the key firms paving the way for growth in the bioinformatics in in-vitro diagnostics (ivd) testing market?
Major companies operating in the bioinformatics in in-vitro diagnostics (IVD) testing market are Siemens Healthineers, International Business Machines Corporation, Medtronic Inc., Parker Hannifin Corp., Illumina Inc, PerkinElmer Inc., QIAGEN N.V., Kollmorgen Corp, Bioreference Laboratories Inc., AssureRx Health Inc., Biodesix Inc., Crescendo Bioscience Inc., Affymetrix, Complete Genomics Inc., Aperico Technologies Inc., One Lambda Inc., Datech Oncology, Life Technologies, Signal genetics, CardioDx Inc.
Which trends are expected to transform the bioinformatics in in-vitro diagnostics (ivd) testing market?
Key players in the bioinformatics for IVD testing market are working on innovations like next-generation sequencing (NGS) technology to improve genetic mutation detection and diagnostic precision. NGS allows for the rapid sequencing of DNA or RNA to analyze genetic variations. For example, in May 2022, Illumina Inc. launched a pan-cancer companion diagnostic (CDx) indication for its TruSight Oncology Comprehensive test. This test identifies cancer patients with NTRK gene fusions, enabling targeted therapy with Bayer’s Vitrakvi, improving the molecular profile of cancer diagnoses.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16629
What regions are contributing significantly to the growth of the bioinformatics in in-vitro diagnostics (ivd) testing market?
North America was the largest region in the bioinformatics in in-vitro diagnostics (IVD) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioinformatics in in-vitro diagnostics (IVD) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
In Vitro Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
Hospital Acquired Infections Testing Kits Global Market Report 2024
AI In Bioinformatics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ai-in-bioinformatics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
